Developer docs
API playgroundTry for free, no card

Search company profiles

Analytica

Full company profile

uuid0005acv

Namestring
Analytica
Legal namestring
Analytica Limited
Company typeenum
Public
Founded yearint
1998
Descriptiontext

Analytica Limited (ASX: ALT, ABN 12 006 464 866) is a Brisbane-based medical device company that developed two complementary product lines: PeriCoach, an e-health system for the conservative treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in women, and AutoStart, an IV infusion burette with automatic flow-restart functionality. The company's lead asset, PeriCoach, comprises a pelvic floor exercise device equipped with patented force-sensor and motion-sensing technology, paired with a smartphone application and the PeriCloud web portal that enables physicians to remotely monitor patient compliance and symptom progression. AutoStart is a specialised IV burette whose enhanced float mechanism restarts fluid flow after medicated bolus delivery, designed to reduce nurse intervention; it received USFDA 510(k) clearance in 2010 and is listed on the Australian Register of Therapeutic Goods.

The company operated two distinct go-to-market models. PeriCoach was sold direct-to-consumer globally through the owned PeriCoach.com storefront, leveraging regulatory clearances in Australia (TGA), Europe (CE mark), and the United States (FDA 510(k)) for Stress Urinary Incontinence, plus TGA clearance for Pelvic Organ Prolapse. AutoStart was distributed through regional partners across Australia/New Zealand, Taiwan/South-East Asia, and Brazil/South America, and was listed on the Queensland Health purchasing schedule. Distribution was supplemented in 2018 by a US contract manufacturer for PeriCoach, and in May 2022 the company received ISO 13485:2016 certification enabling global sales of in-house manufactured product.

From 2014 through 2021 Analytica funded operations primarily through a series of small rights issues, placements, and option exercises totalling roughly AUD 8.7M, supplemented by R&D tax incentives from the Australian Taxation Office (AUD 649K for FY2020 and AUD 269K for FY2021) and a $4.8M federal grant commitment announced in May 2022 for a manufacturing facility in Maryborough, Queensland. The company entered voluntary administration on 13 June 2023 following an ASX suspension and the May 2023 resignation of CEO Geoff Daly. On 25 July 2023 creditors approved a Deed of Company Arrangement proposed by Stratos MedTech Pty Ltd and Stratos MedTech Holdings Pty Ltd, and the company's assets were sold. The listed entity is now described on its own website as 'Subject to Deed of Company Arrangement,' and no revenue figures have been publicly disclosed.

Short descriptiontext

Analytica Limited is a Brisbane-based medical device company that developed the PeriCoach e-health system for women's pelvic floor disorders and the AutoStart IV infusion burette, serving consumers via PeriCoach.com and hospitals via regional distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBrisbane, Australia
HQ citystring
Brisbane
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pelvic floor devices, IV infusion systems, women's health devices, e-health monitoring, medical device manufacturing
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1PeriCoach Device and System Sales
TypeHardware Sales
Description

Sale of PeriCoach device, web portal access, and smartphone app for treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse

analyticamedical.com
2AutoStart Infusion System Sales
TypeHardware Sales
Description

Sale of AutoStart burette devices with enhanced float system for IV fluid infusion

analyticamedical.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1PeriCoach
Description

An e-health treatment system for women who suffer Stress Urinary Incontinence. Comprises a device, web portal and smartphone app that evaluates pelvic floor muscle activity.

analyticamedical.com
+1 more record
Core offering1 text field

Analytica develops, manufactures, and commercialises Class I and Class IIa medical devices. Its lead product, the PeriCoach System, is an e-health platform combining a pelvic floor muscle-sensing device, a smartphone app, and a cloud-based physician portal (PeriCloud) for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Its secondary product, the AutoStart Infusion System, is an IV burette with automatic flow-restart and flushing capability for hospital infusion therapy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Randomised controlled clinical trial demonstrated PeriCoach non-inferiority to traditional supervised pelvic floor physical therapy for Stress Urinary Incontinence
+2 more records
Product overview1 text field

Analytica offers a portfolio of medical device products focused on two main areas: women's health and infusion systems. The PeriCoach System is an e-health platform combining a pelvic floor exercise device with a smartphone app and PeriCloud web portal for remote patient monitoring. The AutoStart Infusion System is a specialized IV burette that automatically restarts fluid flow after medication delivery. The company also received ISO 13485:2016 certification for design, development, production, sales and distribution of PeriCoach.

Product and service2 records
1PeriCoach System
CategoryWomen's health medical device (Class I/IIa)
Description

An e-health treatment system for women suffering Stress Urinary Incontinence and Pelvic Organ Prolapse. It comprises a pelvic floor muscle-sensing device, a smartphone app, and the PeriCloud web portal that lets physicians remotely monitor whether a patient is performing pelvic floor exercises correctly and whether her condition is improving. The system holds TGA (Australia), CE mark (Europe), and FDA 510(k) (US) regulatory clearances and is sold direct-to-consumer via PeriCoach.com.

2AutoStart Infusion System
CategoryIV infusion medical device
Description

An IV fluid infusion system (burette) with an enhanced float mechanism that automatically restarts IV fluid flow after delivery of a predetermined medication amount, plus an integrated flushing feature allowing the needle-less injection port and medication delivery syringe to be flushed with saline from the IV bag. Designed for hospital and clinical IV infusion therapy to reduce nurse intervention and alarm fatigue, with an estimated $2 cost saving per medication event. Distributed via regional partners across Australia/New Zealand, Taiwan/South-East Asia, and Brazil/South America and listed on the Queensland Health purchasing schedule.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Viveve develops energy-based women's health devices for vaginal laxity, stress urinary incontinence, and sexual function—targeting the same SUI patient cohort as PeriCoach through a device-based clinical positioning.

TypeBroad incumbent
Description

ICU Medical produces IV infusion and oncology drug-delivery products and is a competitor for the infusion-pump accessories market that AutoStart's automatic flow-restart burette targets.

TypeDirect peer
Description

Atlantic Therapeutics markets the INNOVO electrical muscle stimulation system for stress urinary incontinence, directly competing with PeriCoach in the conservative/e-health treatment of pelvic floor dysfunction.

TypeBroad incumbent
Description

Baxter is a major manufacturer of IV infusion pumps, sets, and disposables—operating as a broad incumbent competing for hospital IV contracts where AutoStart's clinical and cost-savings proposition would be evaluated.

5Axonics
TypeBroad incumbent
Description

Axonics offers sacral neuromodulation systems to treat bladder and bowel dysfunction including incontinence—a larger, broader incumbent in the SUI/overactive bladder treatment space that overlaps with PeriCoach's downstream surgical alternatives.

TypeDirect peer
Description

Caldera Medical develops surgical and conservative devices for female pelvic health including stress urinary incontinence, providing direct comparability to Analytica's PeriCoach in the women's pelvic floor market.

TypeBroad incumbent
Description

B. Braun is a large medical device and IV therapy player with infusion and disposables portfolios that directly overlap with Analytica's AutoStart IV burette/infusion system.

TypeDirect peer
Description

Laborie is a urogynecology and pelvic health medical device company focused on diagnostics and therapeutics for incontinence and pelvic floor disorders—overlapping directly with PeriCoach's clinical use case.

TypeBroad incumbent
Description

BD offers a broad portfolio of IV therapy, infusion sets, and medication-delivery products that compete for the same hospital purchasing decisions where AutoStart's value proposition is positioned.

TypeDirect peer
Description

Renovia developed the Leva pelvic floor digital therapeutic for stress urinary incontinence—a direct e-health/biofeedback competitor to PeriCoach targeting the same patient population with a similar remote-monitoring clinical positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Analytica

Medical Devicesanalyticamedical.com

Analytica Limited is a Brisbane-based medical device company that developed the PeriCoach e-health system for women's pelvic floor disorders and the AutoStart IV infusion burette, serving consumers via PeriCoach.com and hospitals via regional distributors.

What Analytica does

Analytica Limited (ASX: ALT, ABN 12 006 464 866) is a Brisbane-based medical device company that developed two complementary product lines: PeriCoach, an e-health system for the conservative treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in women, and AutoStart, an IV infusion burette with automatic flow-restart functionality. The company's lead asset, PeriCoach, comprises a pelvic floor exercise device equipped with patented force-sensor and motion-sensing technology, paired with a smartphone application and the PeriCloud web portal that enables physicians to remotely monitor patient compliance and symptom progression. AutoStart is a specialised IV burette whose enhanced float mechanism restarts fluid flow after medicated bolus delivery, designed to reduce nurse intervention; it received USFDA 510(k) clearance in 2010 and is listed on the Australian Register of Therapeutic Goods.

The company operated two distinct go-to-market models. PeriCoach was sold direct-to-consumer globally through the owned PeriCoach.com storefront, leveraging regulatory clearances in Australia (TGA), Europe (CE mark), and the United States (FDA 510(k)) for Stress Urinary Incontinence, plus TGA clearance for Pelvic Organ Prolapse. AutoStart was distributed through regional partners across Australia/New Zealand, Taiwan/South-East Asia, and Brazil/South America, and was listed on the Queensland Health purchasing schedule. Distribution was supplemented in 2018 by a US contract manufacturer for PeriCoach, and in May 2022 the company received ISO 13485:2016 certification enabling global sales of in-house manufactured product.

From 2014 through 2021 Analytica funded operations primarily through a series of small rights issues, placements, and option exercises totalling roughly AUD 8.7M, supplemented by R&D tax incentives from the Australian Taxation Office (AUD 649K for FY2020 and AUD 269K for FY2021) and a $4.8M federal grant commitment announced in May 2022 for a manufacturing facility in Maryborough, Queensland. The company entered voluntary administration on 13 June 2023 following an ASX suspension and the May 2023 resignation of CEO Geoff Daly. On 25 July 2023 creditors approved a Deed of Company Arrangement proposed by Stratos MedTech Pty Ltd and Stratos MedTech Holdings Pty Ltd, and the company's assets were sold. The listed entity is now described on its own website as 'Subject to Deed of Company Arrangement,' and no revenue figures have been publicly disclosed.

Analytica firmographics

Firmographics
Name
Analytica
Legal name
Analytica Limited
Website
https://analyticamedical.com
Company type
Public
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
Analytica Limited is a Brisbane-based medical device company that developed the PeriCoach e-health system for women's pelvic floor disorders and the AutoStart IV infusion burette, serving consumers via PeriCoach.com and hospitals via regional distributors.
Ownership category
akta.pro rank

Where Analytica is headquartered

Location

Headquarters

HQ city
Brisbane
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Analytica business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. PeriCoach Device and System Sales: Sale of PeriCoach device, web portal access, and smartphone app for treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse
  2. AutoStart Infusion System Sales: Sale of AutoStart burette devices with enhanced float system for IV fluid infusion

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Analytica product offering

Product offering

Core offering

Analytica develops, manufactures, and commercialises Class I and Class IIa medical devices. Its lead product, the PeriCoach System, is an e-health platform combining a pelvic floor muscle-sensing device, a smartphone app, and a cloud-based physician portal (PeriCloud) for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Its secondary product, the AutoStart Infusion System, is an IV burette with automatic flow-restart and flushing capability for hospital infusion therapy.

Product overview

Analytica offers a portfolio of medical device products focused on two main areas: women's health and infusion systems. The PeriCoach System is an e-health platform combining a pelvic floor exercise device with a smartphone app and PeriCloud web portal for remote patient monitoring. The AutoStart Infusion System is a specialized IV burette that automatically restarts fluid flow after medication delivery. The company also received ISO 13485:2016 certification for design, development, production, sales and distribution of PeriCoach.

Differentiator

Problem solved

Functional benefit

Brands

  • PeriCoach: An e-health treatment system for women who suffer Stress Urinary Incontinence. Comprises a device, web portal and smartphone app that evaluates pelvic floor muscle activity.
  • AutoStart Infusion System

Products and services

  • PeriCoach System An e-health treatment system for women suffering Stress Urinary Incontinence and Pelvic Organ Prolapse. It comprises a pelvic floor muscle-sensing device, a smartphone app, and the PeriCloud web portal that lets physicians remotely monitor whether a patient is performing pelvic floor exercises correctly and whether her condition is improving. The system holds TGA (Australia), CE mark (Europe), and FDA 510(k) (US) regulatory clearances and is sold direct-to-consumer via PeriCoach.com.
  • AutoStart Infusion System An IV fluid infusion system (burette) with an enhanced float mechanism that automatically restarts IV fluid flow after delivery of a predetermined medication amount, plus an integrated flushing feature allowing the needle-less injection port and medication delivery syringe to be flushed with saline from the IV bag. Designed for hospital and clinical IV infusion therapy to reduce nurse intervention and alarm fatigue, with an estimated $2 cost saving per medication event. Distributed via regional partners across Australia/New Zealand, Taiwan/South-East Asia, and Brazil/South America and listed on the Queensland Health purchasing schedule.

Quantifiable outcome

  • Randomised controlled clinical trial demonstrated PeriCoach non-inferiority to traditional supervised pelvic floor physical therapy for Stress Urinary Incontinence
  • +2 more outcomes

Companies that use Analytica

Customer profile

Segments3 records

Ideal customer profiles2 records

Analytica technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Analytica partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves8 records

Expansion highlights4 records

Analytica competitors and assessment

Company assessment

Direct peers

  • Viveve Medical: Viveve develops energy-based women's health devices for vaginal laxity, stress urinary incontinence, and sexual function—targeting the same SUI patient cohort as PeriCoach through a device-based clinical positioning.
  • Atlantic Therapeutics: Atlantic Therapeutics markets the INNOVO electrical muscle stimulation system for stress urinary incontinence, directly competing with PeriCoach in the conservative/e-health treatment of pelvic floor dysfunction.
  • Caldera Medical: Caldera Medical develops surgical and conservative devices for female pelvic health including stress urinary incontinence, providing direct comparability to Analytica's PeriCoach in the women's pelvic floor market.
  • Laborie Medical Technologies: Laborie is a urogynecology and pelvic health medical device company focused on diagnostics and therapeutics for incontinence and pelvic floor disorders—overlapping directly with PeriCoach's clinical use case.
  • Renovia Inc. Renovia developed the Leva pelvic floor digital therapeutic for stress urinary incontinence—a direct e-health/biofeedback competitor to PeriCoach targeting the same patient population with a similar remote-monitoring clinical positioning.

Broad incumbents

  • ICU Medical: ICU Medical produces IV infusion and oncology drug-delivery products and is a competitor for the infusion-pump accessories market that AutoStart's automatic flow-restart burette targets.
  • Baxter International: Baxter is a major manufacturer of IV infusion pumps, sets, and disposables—operating as a broad incumbent competing for hospital IV contracts where AutoStart's clinical and cost-savings proposition would be evaluated.
  • Axonics: Axonics offers sacral neuromodulation systems to treat bladder and bowel dysfunction including incontinence—a larger, broader incumbent in the SUI/overactive bladder treatment space that overlaps with PeriCoach's downstream surgical alternatives.
  • B. Braun: B. Braun is a large medical device and IV therapy player with infusion and disposables portfolios that directly overlap with Analytica's AutoStart IV burette/infusion system.
  • Becton, Dickinson and Company (BD): BD offers a broad portfolio of IV therapy, infusion sets, and medication-delivery products that compete for the same hospital purchasing decisions where AutoStart's value proposition is positioned.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Analytica social profiles

Digital presence

Analytica compliance and trust

Trust signal

Compliance3 records

Analytica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Analytica leadership team

Management profile

Number of profiles

Profiles3 records

Analytica funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Analytica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Analytica

What does Analytica do?

Analytica develops, manufactures, and commercialises Class I and Class IIa medical devices. Its lead product, the PeriCoach System, is an e-health platform combining a pelvic floor muscle-sensing device, a smartphone app, and a cloud-based physician portal (PeriCloud) for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Its secondary product, the AutoStart Infusion System, is an IV burette with automatic flow-restart and flushing capability for hospital infusion therapy.

Is Analytica a public or private company?

Analytica is a public company. It is classified as public and is currently operating.

When was Analytica founded?

Analytica was founded in 1998. It employs 1 to 10 people.

Where is Analytica based?

Analytica is headquartered in Brisbane, Australia, in the Oceania region.

How does Analytica make money?

Two revenue lines are on record. PeriCoach Device and System Sales are the primary driver. The others are autoStart Infusion System Sales.

Who are Analytica's main competitors?

Direct peers on record are Viveve Medical, Atlantic Therapeutics, Caldera Medical, Laborie Medical Technologies and Renovia Inc.. Broad incumbents are ICU Medical, Baxter International, Axonics, B. Braun and Becton, Dickinson and Company (BD).

Does Analytica have an API?

No public API is recorded for Analytica.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioWorldAnalytica expands into China with JV for urinary incontinence deviceAnalytica Ltd. signed a joint venture agreement with Hebei Nacol Bio-Technology and Shijiazhuang Biosphere to manufacture and distribute its Pericoach urinary incontinence device in China, Macau, Hong Kong, and Taiwan. The deal expands Analytica's presence in the Asia-Pacific market.PR NewswireAnalyse der realen Daten von PeriCoach® zeigen eine statistisch und klinisch bedeutende Reduktion von Inkontinenzsymptomen innerhalb von drei WochenAnalytica Ltd released real-world data analysis of its PeriCoach pelvic floor exercise system, conducted by an independent US biostatistician, showing significant clinical improvements in urinary incontinence symptoms among female users. Over 60% of Version 3 users who used the device for at least three weeks reported a 30% reduction in both incontinence episodes and volume, with over 75% achieving at least 80% improvement by week eight. The company plans to publish the data in urology and women's health journals, with the device currently available in Australia, New Zealand, the United Kingdom, and Ireland following regulatory approvals including FDA 510(k) clearance.PR NewswirePeriCoach® Real-World Data Analysis Reveals Statistically and Clinically Significant Reduction in Incontinence Symptoms Within 3 WeeksAnalytica LTD released real-world data analysis of its PeriCoach version 3 device, showing that users who completed an 8-week challenge achieved significant improvements in incontinence symptoms. An independent US-based biostatistician found that after just three weeks, users experienced a 30% reduction in both leakage episodes (p=.0059) and volume (p=.0017), with more than 75% of users achieving at least 80% improvement by week eight. The company plans to submit the data for publication in urological and women's health journals.News-MedicalPorvair Sciences to showcase microplate and chromatography products at Analytica 2018Porvair Sciences will display its microplate and chromatography products at Analytica 2018 in Munich, including the 96-well SLE microplate and new pierceable cap mats. The SLE microplate enables high-recovery extraction from biological fluids without offline steps, while the cap mats maintain sample integrity for automated chromatography.PR NewswireFDA expands use of PeriCoach at-home pelvic floor trainer device and smartphone app for sexual healthThe U.S. Food and Drug Administration expanded the approved use of Analytica's PeriCoach at-home pelvic floor trainer device to include potential improvement of sexual sensation, satisfaction, and orgasm potential in women, building on its prior approval for treating urinary incontinence. The device, introduced as a prescription product in 2015 and designed by a woman engineer, is now available over-the-counter and marketed in Australia, New Zealand, the UK, Ireland, and the USA. Analytica intends to pursue additional pelvic floor indications such as mild pelvic organ prolapse and fecal incontinence.PR NewswireFDA approves PeriCoach® pelvic floor trainer for sale over-the-counter in the United StatesThe U.S. Food and Drug Administration (FDA) has approved Analytica's PeriCoach® at-home pelvic floor trainer device and smartphone app for over-the-counter sale in the United States, covering treatment of mild, moderate, stress urinary incontinence, and urge incontinence. The device, which has been available by prescription since 2015 and has undergone clinical evaluation including studies by urogynecologists and physical therapists, will be available without a prescription beginning July 18, 2016. This OTC approval represents a significant commercial milestone for Analytica (ASX: ALT) in the U.S. market, expanding access to the estimated one in three women who experience urinary incontinence.